Mar 10 • 07:00 UTC 🇧🇷 Brazil Folha (PT)

Hypertension is a silent disease and screening is flawed in Brazil, say specialists

Experts highlight the inadequacies in hypertension screening in Brazil, emphasizing the serious health risks and challenges faced by patients.

Hypertension, or high blood pressure, is identified as the most prevalent chronic non-communicable disease in Brazil and a leading risk factor for serious health events like heart attacks and strokes. Many patients, such as Silvia Martins, suffer from severe manifestations of the condition and struggle to manage their symptoms effectively despite extensive treatment. Evidence suggests that significant systemic flaws in the health care screening process hinder many individuals from receiving optimal care and timely diagnosis.

The narrative focuses on the experiences of various patients, including Sylvia, who have dealt with long-term hypertension management and the side effects of medication, leading to debilitating health concerns and a significant impact on their quality of life. The report underscores that despite the Brazilian Unified Health System (SUS) attempts to provide treatment, many patients still face significant barriers to effective management, including delayed referrals and insufficient screening protocols.

In light of these challenges, health professionals are calling for improved screening practices and public awareness to better manage hypertension. By addressing these systemic shortcomings, there is hope for enhancing patient outcomes and reducing the adverse health consequences associated with this prevalent chronic disease in Brazil.

📡 Similar Coverage